Abstract
Among the most problematic Gram-positive bacteria with regard to human pathology are Staphylococcal species including S. aureus and S. epidermidis, Enterococcal species including E. faecalis and E. faecium, and Streptococcus species including S. pneumoniae and Group B Streptococcus, among others.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arbeit, R. D., W. W. Karakawa, Vann, W. F. and Robbins, J.B., 1984, Predominance of two newly described capsular polysaccharide types among clincial isolates of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 2:85–91.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T. J., Edwards, J. R., Toison, J., Henderson, T., Martone, W. J, Secular Trends in Nosocomial Primary Bloodstream Infections in the United States, 1980–1989, Am. J. Med., 1991, 91:865–895.
Centers for Disease Control, 1991, Mortality patterns-United States, 1988, Morbid. Mortal. Weekly Rep., 40:493–502.
Centers for Disease Control, 1993, Nosocomial Enterococci Resistant to Vancomycin-United States, 1989–1993, Morbid. Mortal. Weekly Rep., 42:597–599.
Fattom, A., Schneerson, R., Szu, S. C., Vann, W F., Shiloach, J., Karakawa, W. W, and Robbins, J. B., 1990, Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A, Infect. and Immun. 58:2367–2374.
Fattom, A., Schneerson, R., Watson, D. C., Karakawa, W. W., Fitzgerald, D., Pastan, I., Li, X., Shiloach, J., Bryla, D. A., and Robbins, J. B., 1993, Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A, Infect. and Immun. 61:1023–1032.
Fattom, A., Shiloach, J., Bryla, D., Fitzgerald, D., Pastan, I., Karakawa, W. W., Robbins, J. B., and Schneerson, R., 1992, Comparitive immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succin-imidyl-3-(2-pyridyldithio)propionate, Infect. and Immun. 60:584–589.
Fournier, J.M., Vann, W. F. and Karakawa, W. W., 1984, Purification and characterization oi Staphylococcus aureus type 8 capsular polysaccaride, Infect. Immun. 45:87–93.
Hochkeppel, H. K., Braun, D. G., Vischer, W., Imm, A., Sutter, S., Staebubli, U., Genheim, R., Kaplan, E. L., Boutonnier, A. and Fournier, J. M., 1987, Serotyping and electorn microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antobodies to capsular polysaccharides types 5 and 8, J. Clin. Microbiol. 25:526–530.
Karakawa, W. W. and Vann, W. F., 1982, Capsular polysaccharides of Staphyloccus aureus, Semin. Infect. Dis. 4:285–293.
Karakawa, W. W., Sutton, A., Schneerson, R., Karpas, A., and Vann, W. F., 1988, Capsular antibodies induce type-specific phagocytosis of Staphylococcus aureus by human polymorphonuclear leukocytes, Infect. Immun. 56:1090–1095.
Karakawa, W. W., Fournier, J.-M., Vann, W. F., Arbeit, Schneerson, R., and Robbins, J.B, 1986, Methods for the serological typing of the capsular polysaccharides of Staphylococcus aureus, J. Clin. Microbiol. 22:445–447.
Karakawa, W. W., 1992, Editorial. The role of capsular polysaccharide antigens in Staphylococcus aureus, Int. J. Med. Microbiol. 277:415–418.
Moreau, M., Richards, J. C., Fournier, J-M., Byrd, R. A., Karakawa, W. W., and Vann, W. F., 1990, The structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr. Res. 201:285–297.
Panililio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Toison, J. S., and Martone, W. J., Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991, Infec. Control and Hosp. Epidemiol., 1992, 13:582–586.
Robbins, J. B., and Schneerson, R., 1990, Polysaccharide-protein conjugates. A new generation of vaccines. J. Infect. Dis. 161:821–832.
Robbins, J. B., Schneerson, R., Vann, W. F., Bryla, D. A., and Fattom, A., 1995, Prevention of systemic infections caused by Group B Streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. NYAS: Combined Vaccines, New York Acadamy of Science Annals, In Press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Naso, R., Fattom, A. (1996). Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections. In: Cohen, S., Shafferman, A. (eds) Novel Strategies in the Design and Production of Vaccines. Advances in Experimental Medicine and Biology, vol 397. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1382-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1382-1_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1384-5
Online ISBN: 978-1-4899-1382-1
eBook Packages: Springer Book Archive